Melphalan, Prednisone, and CC-5013 (Revlimid) as Induction Therapy in Multiple Myeloma
This study has been completed.
Sponsor:
University of Turin, Italy
Information provided by:
University of Turin, Italy
ClinicalTrials.gov Identifier:
NCT00396045
First received: November 2, 2006
Last updated: November 29, 2006
Last verified: November 2006
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | January 2008 |
| Estimated Primary Completion Date: | No date given |